3M stock appears undervalued by roughly 24.4% based on a Discounted Cash Flow analysis, even as a new PFAS lawsuit from the New York Attorney General adds to potential long-term liabilities. The DCF model estimates an intrinsic value of about $214 per share, compared with a recent price implying a discount, supported by trailing twelve-month free cash flow of approximately $1.8 billion. On an earnings basis, the stock trades at a price-to-earnings ratio of about 30.3 times, below a tailored fair P/E estimate of 33.7 times, though it remains at a premium to the broader Industrials sector average of 12.5 times. Overall valuation checks score 3 out of 6, pointing to a mixed picture rather than a clear bargain, with the discount hinging on whether 3M can convert its cash flow profile into durable, litigation-adjusted value.
3M CompanyDCF analysis suggests stock is undervalued by 24.4% based on cash flow, with intrinsic value ~$214 vs current price.